Show notes
This episode explains minimal residual disease (MRD) - what it is, how it’s measured, and how it could shape more personalised myeloma treatment in the future.
📌Key Takeaways:
Even when blood tests look ‘normal’, tiny amounts of myeloma can still remain - MRD helps find it.
Reaching MRD negativity is a powerful sign - it often means longer, deeper remission.
In the future, MRD could decide when to stop, reduce or restart treatment - but we’re not quite there yet.
For extra content and more resources, please visit our website: https://www.themyelomaminutes.com/
We are proudly partnered with…
Website: share.transistor.fm

